פורסם ב: אופנה ב- שיג'יאצאנג | פורסם: |
Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide.
In a mid-stage clinical trial, the experimental drug retaglutide helped people lose an average of about 24% of their body weight, equivalent to about 58 pounds. The findings were simultaneously published in the New England Journal of Medicine.
It can provide more weight loss than any drug currently on the market. Retatrutide could leapfrog another weight loss drug, tirzepatide, which experts estimated earlier this year could become the best-selling drug of all time.
Whatsapp:+86 19933155940
Wickr: daisyhou
With us, everything is not a problem, we will solve all your problems within our ability.
100% no need to Clear Customs
100% Leave at your front door
100% KEEP Private, no necessary to Sign
Contact this advertiser
